NCT02242149View on ClinicalTrials.gov

Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

October 14, 2014

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2018

Conditions
Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver Disease
Interventions
DRUG

Diacerein

All subjects will be given diacerein with a starting dose of 50 mg in one tablet once daily for 2 weeks. After 2 weeks, they will be given diacerein 50 mg in one tablet twice daily for the duration of sudy.

DRUG

Placebo

Sugar pill manufactured to mimic Diacerein

Trial Locations (1)

21941913

Program of Arterial Hypertension, University Hospital Clementino Fraga Filho, Rio de Janeiro

All Listed Sponsors
collaborator

Rio de Janeiro State Research Supporting Foundation (FAPERJ)

OTHER_GOV

lead

Universidade Federal do Rio de Janeiro

OTHER

NCT02242149 - Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects | Biotech Hunter | Biotech Hunter